Lataa...

Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy

Checkpoint blockade therapy, for example using antibodies against CTLA-4 and PD-1/PD-L1, relieves T cells from the suppression by inhibitory checkpoints in the tumor microenvironment; thereby achieving good outcomes in the treatment of different cancer types. Like T cells, natural killer (NK) cell i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Immunol
Päätekijät: Zhang, Cai, Liu, Yuxia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7344328/
https://ncbi.nlm.nih.gov/pubmed/32714324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01295
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!